DeepRare, developed at Shenhua Hospital, raises rare disease diagnostic accuracy to 57% with clinical data and over 70% with genetics, offering traceable AI reasoning for clinicians worldwide.
How DeepRare Is Redefining Rare Disease Diagnosis in China and Beyond Read More »
A concise translation of a UTAUT study among doctors and nurses in North India: the practical drivers, barriers, and tactical steps hospital leaders and vendors can use to increase clinical AI uptake.
Why Doctors and Nurses Adopt Health AI: Lessons from a UTAUT Study in India Read More »
DeepRare, developed by Shanghai Jiao Tong University and Xinhua Hospital, uses an agentic AI workflow to shorten rare disease diagnosis — outperforming Exomiser in Recall@1.
Agentic AI DeepRare Accelerates Rare Disease Diagnosis with Human-like Reasoning Read More »
How AI is easing mental health demand, reducing surgical backlogs and improving supply chains. Practical examples, policy notes, and a forward-looking outlook.
AI Innovations Addressing Emerging Healthcare Challenges Read More »
Merck teams with Mayo Clinic to combine Mayo Clinic Platform data and Merck’s AI virtual cell tools to speed AI-driven drug discovery for IBD, atopic dermatitis and MS.
Merck and Mayo Clinic Partner to Accelerate AI Drug Discovery Read More »
NHS England recruits external AI clinical-safety expertise, UK Biobank gains GP record access, and £20m funds digital addiction treatments, accelerating UK health AI research.
UK Healthcare’s Digital Horizon: Latest AI & Data Initiatives Read More »
A concise, expert overview of how AI differs from machine learning and how it accelerates drug discovery, diagnostics, and personalized treatment in biotech.
NHS England recruits 50,000 for a genomic mental health study using AI to map risk, predict outcomes and guide personalised treatments.
AI Drives UK’s Landmark Personalized Mental Health Study Read More »
A concise assessment of AI for pulmonary embolism detection: reported accuracy in studies, why performance drops across hospitals, and steps for safer deployment.
AI in Pulmonary Embolism Detection: Promise Versus Practical Readiness Read More »
Mayo Clinic Platform turns de-identified multi-institutional data, privacy-first design, and no-code tools into real-world AI that predicts disease and simulates trials.
How the Mayo Clinic Platform Is Speeding AI from Lab to Clinic Read More »
